Sullivan & Worcester advised Channel, Latham & Watkins advised Ligand, while Kelley Drye & Warren represented Murchinson on the deal. Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) and…
Channel Therapeutics Corporation’s Merger With Pelthos Therapeutics
